← Evidence map

ArticleDiscover oncology2025

SERPINA1 is a new frontier in cancer immunotherapy and drug targeting by pan-cancer analysis.

Chen Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40483643